Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease
Article first published online: 9 OCT 2008
Volume 55, Issue 2, pages 140–148, February 2000
How to Cite
Fogdell-Hahn, A., Ligers, A., Grønning, M., Hillert, J. and Olerup, O. (2000), Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease. Tissue Antigens, 55: 140–148. doi: 10.1034/j.1399-0039.2000.550205.x
- Issue published online: 9 OCT 2008
- Article first published online: 9 OCT 2008
- Received 27 April, revised, accepted for publication 3 November 1999
- allele-specific amplification;
- histocompatibility testing;
- genetic susceptibility;
- HLA class I association;
- multiple sclerosis;
- polymerase chain reaction
This study was supported by grants from the Swedish Medical Research Council, the Childrens’ Cancer Foundation, the Tobias Foundation and the Swedish association of the Neurologically Disabled.
Multiple sclerosis (MS) is a presumed autoimmune disease of the central nervous system, shown to be associated with the HLA class II haplotype DRB1*15,DQB1*06. Carrying the HLA class II haplotype DRB1*15,DQB1*06 increases the risk of MS by 3.6. By adopting a polymerase chain reaction (PCR)-based typing technique for HLA class I and class II genes, 200 Swedish MS patients and 210 Swedish healthy controls were analysed for their HLA alleles. Additional HLA class I alleles that increase and decrease the genetic susceptibility to MS were identified. The HLA-A*0301 allele increases the risk of MS (odds ratio=2.1) independently of DRB1*15,DQB1*06. HLA-A*0201 decreases the overall risk (odds ratio=0.52) and the presence of A*0201 reduces the risk of MS for DRB1*15,DQB1*06 carriers from 3.6 to 1.5. Our findings are the first to identify a major modulating effect of HLA class I alleles on the susceptibility to a human autoimmune disease; a phenomenon that has previously only been observed in animal models.